Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase I study of tauromustine administered in a weekly scheduleS B Gjedde, H T Mouridsen, E L-Madsen, et al.The Journal of Infectious Diseases|May 24, 2000
Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virusJ K Christensen, J Eugen-Olsen, M SŁrensen, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
Multiple-dose pharmacokinetics of epirubicin at four different dose levels: studies in patients with metastatic breast cancerP Jakobsen, E Steiness, L Bastholt, et al.Cancer Chemotherapy and Pharmacology|January 1, 1991
A randomized study of epirubicin at four different dose levels in advanced breast cancer. Feasibility of myelotoxicity prediction through single blood-sample measurementP Jakobsen, L Bastholt, M Dalmark, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1992
Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancerJ Pedersen-Bjergaard, T C Sigsgaard, D Nielsen, et al.Scandinavian Journal of Immunology|August 14, 1999
Bulk culture levels of specific cytotoxic T-cell activity against HIV-1 proteins are not associated with risk of deathH Aladdin, H Ullum, A C Lepri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996
Dose-response relationship of epirubicin in the treatment of postmenopausal patients with metastatic breast cancer: a randomized study of epirubicin at four different dose levels performed by the Danish Breast Cancer Cooperative GroupL Bastholt, M Dalmark, S B Gjedde, et al.Ugeskrift for Laeger|July 6, 1992
[Malignant melanoma of the skin in Denmark--epidemiology, diagnosis and treatment]H von der Maase, A Osterlind, K T Drzewiecki, et al.Pageof 2